CellWell record HH-564304
The effects of stimulated thyroglobulin/ thyroid-stimulating hormone ratio and N1b status on the efficacy of the first I-131 treatment in patients with differentiated thyroid cancer
Supanida Mayurasakorn; Charoonsak Somboonporn; Daris Theerakulpisut
2026
In plain language
In this retrospective study with no specific funding of 227 thyroid cancer patients, the sTg/TSH ratio and N1b lymph node metastasis were not independent risk factors for a non-excellent response to first radioiodine treatment.
- Evidence
- Emerging
- Design
- Observational study
Cite this record: https://thecellwell.org/studies/HH-564304
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.